152 related articles for article (PubMed ID: 25176268)
1. [The assessment of the effects of cytoflavin and cardioxipin on the emotional status of rats with dyslipidemia].
Vodop'ianova OA; Moiseeva IIa; Rodina OP; Kustikova IN; Antropova NV
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(7):53-5. PubMed ID: 25176268
[TBL] [Abstract][Full Text] [Related]
2. [THE INFLUENCE OF CYTOFLAVIN AND CARDIOXIPIN ON THE PARAMETERS OF 24-HOUR ARTERIAL PRESSURE MONITORING IN PATIENTS WITH CHRONIC CEREBRAL CIRCULATION INSUFFICIENCY, ARTERIAL HYPERTENSION AND HYPERCHOLESTEROLEMIA].
Vodop'ianova OA; Moiseeva IIa; Rodina OP; Kustikova IN; Antropova NV
Klin Med (Mosk); 2015; 93(2):67-71. PubMed ID: 26117922
[TBL] [Abstract][Full Text] [Related]
3. [The influence of cytoflavin and cardioxipin on the indices of lipid peroxidation and antioxidant protection in the blood of rat with dyslipidemia].
Vodop'ianova OA; Moiseeva IIa; Rodina OP; Kustikova IN; Antropova NV
Eksp Klin Farmakol; 2014; 77(6):27-9. PubMed ID: 25102732
[TBL] [Abstract][Full Text] [Related]
4. [Experimental study on cytoflavin pharmacological correction of cyclophosphamide-induced toxic affections of the liver and kidneys].
Kashuro VA; Glushkov SI; Minaeva LV; Novikova TM
Antibiot Khimioter; 2010; 55(9-10):29-32. PubMed ID: 21400751
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of cytoflavin in therapy of encephalophathy in patients with neuroinfection].
Isakov VA; Kovalenko AL; Turkin VV; Makarov VI
Antibiot Khimioter; 2010; 55(1-2):36-41. PubMed ID: 20583556
[TBL] [Abstract][Full Text] [Related]
6. [Effect of cytoflavin on some physiological values in patients with toxicohypoxic encephalopathy].
Livanov GA; Lodiagin AN; Andrianov AIu; Batotsyrenov BV; Nikolaeva IP
Eksp Klin Farmakol; 2013; 76(11):40-3. PubMed ID: 24555233
[TBL] [Abstract][Full Text] [Related]
7. [The use of cytoflavin in sports nutrition].
Kosinets VA; Stolbitskiĭ VV; Shturich IP
Klin Med (Mosk); 2012; 90(7):56-8. PubMed ID: 23019978
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of cytoflavin in the treatment of vertebrobasilar insufficiency].
Beĭn BN; Dravert NE
Eksp Klin Farmakol; 2010 Apr; 73(4):8-10. PubMed ID: 20486551
[TBL] [Abstract][Full Text] [Related]
9. [Comparative experimental study of antioxidant efficiency in treatment of acute pancreatitis].
Kliuĭko DA; Korik VE; Zhidkov SA
Eksp Klin Farmakol; 2011; 74(9):11-5. PubMed ID: 22164440
[TBL] [Abstract][Full Text] [Related]
10. [Study cytoflavin dose-dependent effect in the treatment of acute ischemic stroke].
Sazonov IE; Kudinov AA; Fedotova EP
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(2):64-67. PubMed ID: 28374695
[TBL] [Abstract][Full Text] [Related]
11. [Using cytoflavin for prophylaxis and treatment of cognitive amnestic disorders in patients with heavy toxicohypoxic damage of brain].
Batotsyrenova KhV; Livanov GA; Shestova GV; Sizova KV; Velikova VD
Eksp Klin Farmakol; 2012; 75(9):28-31. PubMed ID: 23156085
[TBL] [Abstract][Full Text] [Related]
12. [Investigation of the antioxidant activity and cardioprotective effect of reamberin and cytoflavin in newborn rats exposed to chronic hemic hypoxia].
Zadnipryanyi IV; Tretyakova OS; Sataeva TP
Arkh Patol; 2015; 77(6):39-44. PubMed ID: 26841648
[TBL] [Abstract][Full Text] [Related]
13. [EFFECTIVENESS OF CYTOFLAVIN FOR THE CORRECTION OF COGNITIVE IMPAIRMENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS].
Gatskikh IV; Veselova OF; Brikman IN; Shalda TP; Varygina EL; Kuznetsov MN; Shul'min AV; Petrova MM
Eksp Klin Farmakol; 2015; 78(11):21-5. PubMed ID: 27017701
[TBL] [Abstract][Full Text] [Related]
14. [Correction of central nervous system energy processes in children with the minimal cerebral dysfunction].
Lavrik SIu; Domitrak SV; Shprakh VV
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(4):37-41. PubMed ID: 21512499
[TBL] [Abstract][Full Text] [Related]
15. [Cytoflavin in total intravenous anesthesia].
Ovezov AM; Bragina SV; Prokoshev PV
Vestn Khir Im I I Grek; 2010; 169(2):64-7. PubMed ID: 20552794
[TBL] [Abstract][Full Text] [Related]
16. [The results of using cytoflavin in conservative treatment of patients with obliterating atherosclerosis of the lower extremity vessels].
Bogomolov MS; Sedov VM; Edovina LN; Luk'ianov IuV; Slobodianiuk VV
Vestn Khir Im I I Grek; 2011; 170(1):43-6. PubMed ID: 21506354
[TBL] [Abstract][Full Text] [Related]
17. [Dynamics of the symptoms of chronic ischemia during the treatment with cytoflavin].
Madzhidova EN; Usmanova DD; Baĭtursunova ZhM
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(9):57-62. PubMed ID: 23235414
[TBL] [Abstract][Full Text] [Related]
18. [Clinical and morphologic efficacy of a complex antioxidant and energy correction therapy of different duration in brain infarction: results of a multicenter randomized trial].
Rumyantsevа SA; Kovalenko AL; Silinа EV; Stupin VA; Kabaeva EN; Chichanovskaya LV; Nazarov MV; Tsukurova LA; Burenichev DV; Golikov KV; Salnikov MV; Belova LA; Mashin VV; Mazina NK; Zhilina EA; Kolotik-Kameneva OY; Sherman MA
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(8):45-52. PubMed ID: 26356615
[TBL] [Abstract][Full Text] [Related]
19. [Modern methods of energy homeostasis correction in elderly patients].
Rumiantseva SA; Silina EV; Tsukurova LA; Stupin VA; Chichanovskaia LV; Nazarov MV; Kovalenko AL; Kabaeva EN
Adv Gerontol; 2014; 27(4):746-52. PubMed ID: 25946854
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of the energy-modifier cytoflavin in the treatment of patients with hypertensive encephalopathy].
Belova LA; Kolotik-Kameneva OIu; Mashin VV; Saprygina LV; Mashin EV
Ter Arkh; 2014; 86(9):65-70. PubMed ID: 25518508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
